Patents by Inventor Yajun ZHENG

Yajun ZHENG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11289110
    Abstract: A method and device for audio signal processing is provided. The method includes steps of: obtaining an inputted audio signal; parsing the audio signal to obtain at least one audio feature; determining at least one vibration feature corresponding to the at least one audio feature; and generating a vibration signal corresponding to the audio signal according to the at least one vibration feature. The inputted audio signal is automatically converted into a vibration signal by the vibration feature corresponding to the audio feature of the inputted audio signal, which can avoid errors caused by manual operation and make the vibration signal possess high versatility.
    Type: Grant
    Filed: December 5, 2019
    Date of Patent: March 29, 2022
    Assignee: AAC Technologies Pte. Ltd.
    Inventors: Yajun Zheng, Hanlin Deng, Xiang Lu, Yulei Zhang
  • Patent number: 11264931
    Abstract: The invention provides a vibration controlling method which amplifies a steady state voltage and generates a first voltage signal for controlling the vibrator to accelerate vibration to a target vibration amplitude lower than the steady state vibration amplitude, and then attenuates the startup voltage to the steady state voltage to generate a second voltage signal for controlling the vibrator to vibrate from the target vibration amplitude to the steady state vibration amplitude. Through the implementation of the invention, the steady state voltage is amplified and used as an excitation voltage of the acceleration section of vibrator vibration, and then it steadily decreases to the steady state voltage, which effectively shortens the acceleration time for the early stage of the vibrator vibration response and reduces the hysteresis of the vibrator vibration fed back to the user.
    Type: Grant
    Filed: August 13, 2020
    Date of Patent: March 1, 2022
    Assignee: AAC Technologies Pte. Ltd.
    Inventors: Yajun Zheng, Zheng Xiang, Chengyan Sang
  • Patent number: 11180494
    Abstract: The invention relates to compounds of formula (I): or a salt thereof, wherein R1, G, L1, L2, L3, and Y are as described herein. Compounds of formula (I) and pharmaceutical compositions thereof are inhibitors of one, or both of, ?v?1 integrin and ?v?6 integrin that are useful for treating fibrosis such as in nonalcoholic steatohepatitis (NASH), idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP).
    Type: Grant
    Filed: October 8, 2019
    Date of Patent: November 23, 2021
    Assignee: Pliant Therapeutics, Inc.
    Inventors: Jacob Cha, Manuel Munoz, Maureen Reilly, Nicole Cooper, Katerina Leftheris, David J. Morgans, Jr., Timothy Hom, Yajun Zheng
  • Publication number: 20210238174
    Abstract: Provided are novel compounds of Formula (I): pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the treatment of diseases and disorders mediated by ROR?. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I) and methods for their use in treating one or more inflammatory, metabolic, autoimmune and other diseases or disorders.
    Type: Application
    Filed: September 9, 2020
    Publication date: August 5, 2021
    Inventors: David A. Claremon, Lawrence Wayne Dillard, Chengguo Dong, Yi Fan, Lanqi Jia, Zhijie Liu, Stephen D. Lotesta, Andrew Marcus, Suresh B. Singh, Colin M. Tice, Jing Yuan, Wei Zhao, Yajun Zheng, Linghang Zhuang
  • Publication number: 20210179611
    Abstract: The present invention is directed to inhibitors of the interaction of menin with MLL and MLL fusion proteins, pharmaceutical compositions containing the same, and their use in the treatment of cancer and other diseases mediated by the menin-MLL interaction.
    Type: Application
    Filed: August 11, 2020
    Publication date: June 17, 2021
    Applicant: Vitae Pharmaceuticals, LLC
    Inventors: Salvacion CACATIAN, David A. CLAREMON, Chengguo DONG, Yi FAN, Lanqi JIA, Stephen D. LOTESTA, Suresh B. SINGH, Shankar VENKATRAMAN, Jing YUAN, Yajun ZHENG, Linghang ZHUANG
  • Patent number: 11025187
    Abstract: A method of generating motor driving signal includes: obtaining acceleration segment signal for driving motor to start vibrating, constant segment signal for achieving low-frequency vibration tactile effect of the motor, and attenuating segment signal for decreasing vibration quantity of the motor in low frequency manner, frequency of constant segment signal and of attenuating segment signal being smaller than frequency of acceleration segment signal; splicing the acceleration segment signal with the constant segment signal, and reserving idle period with no signal output therebetween to obtain first motor driving signal; adjusting parameter of constant segment signal of first motor driving signal according to vibration feeling requirement, and splicing attenuating segment signal after the adjusted first motor driving signal to obtain second motor driving signal; and adjusting parameter of attenuating segment signal of second motor driving signal, and determining second motor driving signal with highest braki
    Type: Grant
    Filed: December 4, 2019
    Date of Patent: June 1, 2021
    Assignee: AAC Technologies Pte. Ltd.
    Inventors: Hanlin Deng, Xiang Lu, Yajun Zheng, Xiuyue Wang
  • Publication number: 20210053974
    Abstract: The present invention is directed to inhibitors of the interaction of menin with MLL and MLL fusion proteins, pharmaceutical compositions containing the same, and their use in the treatment of cancer and other diseases mediated by the menin-MLL interaction.
    Type: Application
    Filed: April 1, 2020
    Publication date: February 25, 2021
    Applicant: VITAE PHARMACEUTICALS, LLC
    Inventors: Salvacion CACATIAN, David A. CLAREMON, Lawrence Wayne DILLARD, Chengguo DONG, Yi FAN, Lanqi JIA, Stephen D. LOTESTA, Andrew MARCUS, Angel MORALES-RAMOS, Suresh B. SINGH, Shankar VENKATRAMAN, Jing YUAN, Yajun ZHENG, Linghang ZHUANG, Stephan D. PARENT, Travis L. HOUSTON
  • Publication number: 20210044237
    Abstract: A method for adaptive motor control includes acquiring current parameters in an operation process of the motor at a current moment; determining a type of a region in which the motor operates at the current moment according to the current parameters; triggering a corresponding motor model according to the type of the region in which the motor operates at the current moment; and inputting the current parameters into the corresponding motor model, generating control parameters for motor operation according to the current parameters, and controlling the operation of the motor according to the control parameters for motor operation. An apparatus and a computer-readable storage medium are also disclosed. In comparison with the conventional motor control which uses the single nonlinear model, the motor control method disclosed herein can greatly improve the reliability of the control.
    Type: Application
    Filed: July 29, 2020
    Publication date: February 11, 2021
    Inventors: Xiang Lu, Zheng Xiang, Yajun Zheng
  • Publication number: 20210036644
    Abstract: A motor vibration method and a motor vibration device are provided. The motor vibration method includes: receiving a vibration instruction, and acquiring target environmental data by a preset sensor, wherein the target environmental data includes one or more of environmental noise data, acceleration data and/or pressure data; determining a first vibration signal according to the target environmental data; generating a target vibration signal according to the first vibration signal and a preset second vibration signal, wherein a first frequency of the first vibration signal is greater than a second frequency of the second vibration signal; and controlling the motor to vibrate according to the target vibration signal. The method combines a traditional vibration reminding effect and a sound reminding effect provided by adding the medium- and high-frequency signal, thereby enhancing the reminding efficiency by means of motor vibration and increasing the successful rate of message delivery.
    Type: Application
    Filed: August 17, 2020
    Publication date: February 4, 2021
    Inventors: Yajun Zheng, Yulei Zhang, Chengyan Sang
  • Patent number: 10899758
    Abstract: The present invention is directed to inhibitors of the interaction of menin with MLL and MLL fusion proteins, pharmaceutical compositions containing the same, and their use in the treatment of cancer and other diseases mediated by the menin-MLL interaction.
    Type: Grant
    Filed: September 15, 2017
    Date of Patent: January 26, 2021
    Assignee: VITAE PHARMACEUTICALS, LLC
    Inventors: Salvacion Cacatian, David A. Claremon, Chengguo Dong, Yi Fan, Lanqi Jia, Stephen D. Lotesta, Suresh B. Singh, Shankar Venkatraman, Jing Yuan, Yajun Zheng, Linghang Zhuang
  • Publication number: 20210018565
    Abstract: A method and an apparatus for displaying information of a motor are provided. The method includes: acquiring a target category identifier of a target motor; determining a category parameter interface according to the target category identifier, and displaying the category parameter interface, wherein the category parameter interface displays a category parameter tag that prompts a user to enter parameter information corresponding to the category parameter tag; acquiring target parameter information entered by the user via the category parameter interface; and obtaining target display information corresponding to the target category identifier according to the target parameter information, and displaying the target display information.
    Type: Application
    Filed: August 17, 2020
    Publication date: January 21, 2021
    Inventors: Yingming Qin, Yajun Zheng, Xiaojie Shao
  • Publication number: 20210017171
    Abstract: The invention relates to compounds of formula (A) and formula (I): or a salt thereof, wherein R1, R2, R10, R11, R12, R13, R14, R15, R16, q and p are as described herein. Compounds of formula (A), formula (I), and pharmaceutical compositions thereof are ?v?6 integrin inhibitors that are useful for treating fibrosis such as idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP).
    Type: Application
    Filed: June 26, 2020
    Publication date: January 21, 2021
    Inventors: Jacob CHA, Chengguo DONG, Timothy HOM, Lan JIANG, Katerina LEFTHERIS, Hui LI, David John MORGANS, JR., Manuel MUNOZ, Maureen REILLY, Yajun ZHENG
  • Publication number: 20200403545
    Abstract: The invention provides a vibration controlling method which amplifies a steady state voltage and generates a first voltage signal for controlling the vibrator to accelerate vibration to a target vibration amplitude lower than the steady state vibration amplitude, and then attenuates the startup voltage to the steady state voltage to generate a second voltage signal for controlling the vibrator to vibrate from the target vibration amplitude to the steady state vibration amplitude. Through the implementation of the invention, the steady state voltage is amplified and used as an excitation voltage of the acceleration section of vibrator vibration, and then it steadily decreases to the steady state voltage, which effectively shortens the acceleration time for the early stage of the vibrator vibration response and reduces the hysteresis of the vibrator vibration fed back to the user.
    Type: Application
    Filed: August 13, 2020
    Publication date: December 24, 2020
    Inventors: Yajun Zheng, Zheng Xiang, Chengyan Sang
  • Publication number: 20200352942
    Abstract: The invention relates to dosage forms for daily administration of compounds of formula (A) and formula (I): or a salt thereof, wherein R1, R2, R10, R11, R12, R13, R14, R15, R16, q and p are as described herein. Compounds of formula (A), formula (I), and pharmaceutical compositions thereof are ?v?6 integrin inhibitors that are useful for treating fibrosis such as idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP).
    Type: Application
    Filed: April 8, 2020
    Publication date: November 12, 2020
    Inventors: Jacob CHA, Chengguo DONG, Timothy HOM, Lan JIANG, Katerina LEFTHERIS, Hui LI, David J. MORGANS, JR., Manuel MUNOZ, Maureen REILLY, Yajun ZHENG, Martin DECARIS, Scott TURNER
  • Publication number: 20200339566
    Abstract: Provided are novel compounds of Formula (I): pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the treatment of diseases and disorders mediated by ROR?. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I) and methods for their use in treating one or more inflammatory, metabolic, autoimmune and other diseases or disorders.
    Type: Application
    Filed: January 24, 2020
    Publication date: October 29, 2020
    Inventors: David A. Claremon, Lawrence Wayne Dillard, Chengguo Dong, Yi Fan, Lanqi Jia, Stephen D. Lotesta, Andrew Marcus, Suresh B. Singh, Colin M. Tice, Jing Yuan, Wei Zhao, Yajun Zheng, Linghang Zhuang
  • Patent number: 10807980
    Abstract: Provided are novel compounds of Formula (I): pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the treatment of diseases and disorders mediated by ROR?. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I) and methods for their use in treating one or more inflammatory, metabolic, autoimmune and other diseases or disorders.
    Type: Grant
    Filed: July 9, 2019
    Date of Patent: October 20, 2020
    Assignee: Vitae Pharmaceuticals, LLC
    Inventors: David A. Claremon, Lawrence Wayne Dillard, Chengguo Dong, Yi Fan, Lanqi Jia, Zhijie Liu, Stephen D. Lotesta, Andrew Marcus, Suresh B. Singh, Colin M. Tice, Jing Yuan, Wei Zhao, Yajun Zheng, Linghang Zhuang
  • Patent number: 10793564
    Abstract: The invention relates to compounds of formula (A) and formula (I): or a salt thereof, wherein R1, R2, R10, R11, R12, R13, R14, R15, R16, q and p are as described herein. Compounds of formula (A), formula (I), and pharmaceutical compositions thereof are ?v?6 integrin inhibitors that are useful for treating fibrosis such as idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP).
    Type: Grant
    Filed: March 7, 2019
    Date of Patent: October 6, 2020
    Assignee: PLIANT THERAPEUTICS, INC.
    Inventors: Jacob Cha, Chengguo Dong, Timothy Hom, Lan Jiang, Katerina Leftheris, Hui Li, David J. Morgans, Jr., Manuel Munoz, Maureen Reilly, Yajun Zheng
  • Publication number: 20200211577
    Abstract: A method and device for audio signal processing is provided. The method includes steps of: obtaining an inputted audio signal; parsing the audio signal to obtain at least one audio feature; determining at least one vibration feature corresponding to the at least one audio feature; and generating a vibration signal corresponding to the audio signal according to the at least one vibration feature. The inputted audio signal is automatically converted into a vibration signal by the vibration feature corresponding to the audio feature of the inputted audio signal, which can avoid errors caused by manual operation and make the vibration signal possess high versatility.
    Type: Application
    Filed: December 5, 2019
    Publication date: July 2, 2020
    Inventors: Yajun Zheng, Hanlin Deng, Xiang Lu, Yulei Zhang
  • Publication number: 20200212832
    Abstract: A method of generating motor driving signal includes: obtaining acceleration segment signal for driving motor to start vibrating, constant segment signal for achieving low-frequency vibration tactile effect of the motor, and attenuating segment signal for decreasing vibration quantity of the motor in low frequency manner, frequency of constant segment signal and of attenuating segment signal being smaller than frequency of acceleration segment signal; splicing the acceleration segment signal with the constant segment signal, and reserving idle period with no signal output therebetween to obtain first motor driving signal; adjusting parameter of constant segment signal of first motor driving signal according to vibration feeling requirement, and splicing attenuating segment signal after the adjusted first motor driving signal to obtain second motor driving signal; and adjusting parameter of attenuating segment signal of second motor driving signal, and determining second motor driving signal with highest braki
    Type: Application
    Filed: December 4, 2019
    Publication date: July 2, 2020
    Inventors: Hanlin Deng, Xiang Lu, Yajun Zheng, Xiuyue Wang
  • Patent number: 10683302
    Abstract: The present invention is directed to inhibitors of the interaction of menin with MLL and MLL fusion proteins, pharmaceutical compositions containing the same, and their use in the treatment of cancer and other diseases mediated by the menin-MLL interaction.
    Type: Grant
    Filed: June 8, 2017
    Date of Patent: June 16, 2020
    Assignee: VITAE PHARMACEUTICALS, LLC
    Inventors: Salvacion Cacatian, David A. Claremon, Lawrence Wayne Dillard, Chengguo Dong, Yi Fan, Lanqi Jia, Stephen D. Lotesta, Andrew Marcus, Angel Morales-Ramos, Suresh B. Singh, Shankar Venkatraman, Jing Yuan, Yajun Zheng, Linghang Zhuang, Stephan D. Parent, Travis L. Houston